Modulight: 2023 landed below targets
Modulight said its revenue for 2023 will be around 4 MEUR and its EBIT will deteriorate year-on-year. The guidance marks the third consecutive year of business contraction and a clear shortfall against the company's own targets. We are revising our forecasts for the coming years moderately downwards with the visibility being very low. With the forecast cuts, the stock still looks expensive both in absolute terms and relative to peers. In the coming year, new commercializations can give greater visibility to the company's future.
Modulight
Modulight operates in the technology industry. The company designs, markets, and produces biomedical laser products used in oncology, genetics, and ophthalmology. The customers primarily consist of hospitals and corporate customers operating in medical technology. In addition to the main business, various value-added services are also offered. Their main market is the US.
Read more on company pageKey Estimate Figures02/01
2022 | 23e | 24e | |
---|---|---|---|
Revenue | 4.6 | 4.0 | 8.0 |
growth-% | -49.30 % | -12.89 % | 98.83 % |
EBIT (adj.) | -7.8 | -9.4 | -3.4 |
EBIT-% (adj.) | -169.49 % | -233.81 % | -43.27 % |
EPS (adj.) | -0.20 | -0.21 | -0.08 |
Dividend | 0.00 | 0.00 | 0.00 |
Dividend % | |||
P/E (adj.) | - | - | - |
EV/EBITDA | - | - | - |